IL15 and acute myeloid leukemia: Nevertheless, the IL-15 superagonist complex N-803 reduces clinical responses in AML patients treated with haploidentical ML-NK cells because of CD8+ T lymphocytes stimulation (NCT03050216 and NCT01898793) (136).